Newsflash:
- Better T2DM Glycemic Control Achieved When Pharmacists and Physicians Collaborated
- Progeria Treatment Within Reach? Drug May Target Accelerated Aging Enzyme in Children
- Colitis Nod Puts J&J's Simponi One Step Closer to Blockbuster
- Novo Nordisk Says Completes Hemophilia Drug Trial
- Pfizer Halts Study of Lymphoma Drug Unlikely to Help Survival
- FDA Staff Says Merck's Sleep Drug Effective, Questions Dosage
Investigational Hormone Replacement Promising Treatment for Rare Disorder
Medical Xpress (06/25/12)
Researchers have released the results of a study that examined the effectiveness of using recombinant human parathyroid hormone, or rhPTH(1-84), in the treatment of hypoparathyroidism. The researchers found that using rhPTH(1-84) to treat people with this condition resulted in improved calcium regulation and reduced the amount of calcium and active vitamin D that was required in more than half of patients. The results of this study were presented at The Endocrine Society's 94th Annual Meeting.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
